Amedeo Smart

Free Medical Literature Service

 

Amedeo

Antiretroviral Therapy
  Free Subscription

Articles published in
J Virol
    October 2023
  1. KUSE N, Gatanaga H, Zhang Y, Chikata T, et al
    Epitope-dependent effect of long-term cART on maintenance and recovery of HIV-1-specific CD8(+) T cells.
    J Virol. 2023 Oct 25:e0102423. doi: 10.1128/jvi.01024.
    >> Share

    September 2023
  2. HSIEH SH, Yu FH, Huang KJ, Wang CT, et al
    HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
    J Virol. 2023 Sep 6:e0094823. doi: 10.1128/jvi.00948.
    >> Share

    April 2023
  3. ZHANG L, Yang J, Li H, Zhang Z, et al
    Enterovirus D68 Infection Induces TDP-43 Cleavage, Aggregation, and Neurotoxicity.
    J Virol. 2023 Apr 11:e0042523. doi: 10.1128/jvi.00425.
    >> Share

    December 2022
  4. KIM S, Filsinger Interrante MV, Kim PS
    Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
    J Virol. 2022 Dec 21:e0164722. doi: 10.1128/jvi.01647.
    >> Share

    July 2022
  5. RATCLIFF AN, Venner CM, Olabode AS, Knapp J, et al
    Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope.
    J Virol. 2022 Jul 5:e0185121. doi: 10.1128/jvi.01851.
    >> Share

    June 2022
  6. PEDERSEN SF, Collora JA, Kim RN, Yang K, et al
    Inhibition of a Chromatin and Transcription Modulator, SLTM, Increases HIV-1 Reactivation Identified by a CRISPR Inhibition Screen.
    J Virol. 2022 Jun 22:e0057722. doi: 10.1128/jvi.00577.
    >> Share

    February 2022
  7. PRIMADHARSINI PP, Nagashima S, Nishiyama T, Takahashi M, et al
    Development of recombinant infectious hepatitis E virus harboring the nanoKAZ gene and its application in drug screening.
    J Virol. 2022 Feb 2:jvi0190621. doi: 10.1128/jvi.01906.
    >> Share

    January 2022
  8. RICHTER E, Bornemann L, Korencak M, Alter G, et al
    Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors.
    J Virol. 2022 Jan 12:JVI0173021. doi: 10.1128/JVI.01730.
    >> Share

    November 2021
  9. WU C, He Y, Zhao J, Luo K, et al
    Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption.
    J Virol. 2021 Nov 24:JVI0178521. doi: 10.1128/JVI.01785.
    >> Share

  10. KHATUN M, Kumar K, Baidya A, Mondal RK, et al
    Variability in the response of HBV D-subgenotypes to antiviral therapy: designing pan D-subgenotypic reverse transcriptase inhibitors.
    J Virol. 2021 Nov 3:JVI0180021. doi: 10.1128/JVI.01800.
    >> Share

    June 2021
  11. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Biochemical and structural properties of entecavir-resistant hepatitis B virus polymerase with L180M/M204V mutations.
    J Virol. 2021 Jun 2:JVI0240120. doi: 10.1128/JVI.02401.
    >> Share

    May 2021
  12. RUBIO AA, Filsinger Interrante MV, Bell BN, Brown CL, et al
    A derivative of the D5 monoclonal antibody that targets the gp41 N-heptad repeat of HIV-1 with broad tier-2 neutralizing activity.
    J Virol. 2021 May 12. pii: JVI.02350-20. doi: 10.1128/JVI.02350.
    >> Share

  13. PASSAES C, Delagreverie HM, Avettand-Fenoel V, David A, et al
    Ultrasensitive detection of p24 in plasma samples from people with primary and chronic HIV-1 infection.
    J Virol. 2021 May 5. pii: JVI.00016-21. doi: 10.1128/JVI.00016.
    >> Share

    April 2021
  14. REINHARZ V, Ishida Y, Tsuge M, Durso-Cain K, et al
    Understanding hepatitis B virus dynamics and the antiviral effect of interferon-alpha treatment in humanized chimeric mice.
    J Virol. 2021 Apr 28. pii: JVI.00492-20. doi: 10.1128/JVI.00492.
    >> Share

    March 2021
  15. RANKOVIC S, Deshpande A, Harel S, Aiken C, et al
    HIV-1 uncoating occurs via a series of rapid biomechanical changes in the core related to individual stages of reverse transcription.
    J Virol. 2021 Mar 10. pii: JVI.00166-21. doi: 10.1128/JVI.00166.
    >> Share

    November 2020
  16. REED JC, Solas D, Kitaygorodskyy A, Freeman B, et al
    Identification of an antiretroviral small molecule that appears to be a host-targeting inhibitor of HIV-1 assembly.
    J Virol. 2020 Nov 4. pii: JVI.00883-20. doi: 10.1128/JVI.00883.
    >> Share

    September 2020
  17. HOFFMANN AR, Guha S, Wu E, Ghimire J, et al
    Broad-Spectrum Antiviral Entry Inhibition by Interfacially-Active Peptides.
    J Virol. 2020 Sep 9. pii: JVI.01682-20. doi: 10.1128/JVI.01682.
    >> Share

  18. KHANAL S, Tang Q, Cao D, Zhao J, et al
    Telomere and ATM dynamics in CD4 T cell depletion in active and virus-suppressed HIV infection.
    J Virol. 2020 Sep 9. pii: JVI.01061-20. doi: 10.1128/JVI.01061.
    >> Share

    May 2020
  19. YU D, Xue J, Wei H, Cong Z, et al
    Therapeutic efficacy and resistance selection of a lipopeptide fusion inhibitor in simian immunodeficiency virus (SIV)-infected rhesus macaques.
    J Virol. 2020 May 13. pii: JVI.00384-20. doi: 10.1128/JVI.00384.
    >> Share

    January 2020
  20. ZURNIC BONISCH I, Dirix L, Lemmens V, Borrenberghs D, et al
    Capsid labelled HIV to investigate the role of capsid during nuclear import and integration.
    J Virol. 2020 Jan 15. pii: JVI.01024-19. doi: 10.1128/JVI.01024.
    >> Share

    December 2019
  21. BEAUCLAIR G, Naimo E, Dubich T, Ruckert J, et al
    Targeting the Kaposi Sarcoma Herpesvirus ORF 21 tyrosine kinase and viral lytic reactivation by tyrosine kinase inhibitors approved for clinical use.
    J Virol. 2019 Dec 11. pii: JVI.01791-19. doi: 10.1128/JVI.01791.
    >> Share

  22. WANG V, Davis DA, Deleage C, Brands C, et al
    Induction of Kaposi Sarcoma Associated Herpesvirus-encoded Thymidine Kinase (ORF21) by X-Box Binding Protein-1.
    J Virol. 2019 Dec 4. pii: JVI.01555-19. doi: 10.1128/JVI.01555.
    >> Share

  23. HERNANDEZ MM, Fahrny A, Jayaprakash A, Gers-Huber G, et al
    Impact of suboptimal APOBEC3G neutralization on the emergence of HIV drug resistance in humanized mice.
    J Virol. 2019 Dec 4. pii: JVI.01543-19. doi: 10.1128/JVI.01543.
    >> Share

    November 2019
  24. KATUSIIME MG, Halvas EK, Wright I, Joseph K, et al
    Intact HIV proviruses persist in children 7-9 years after initiation of ART in the first year of life.
    J Virol. 2019 Nov 27. pii: JVI.01519-19. doi: 10.1128/JVI.01519.
    >> Share

    October 2019
  25. ZHU Y, Ding X, Yu D, Chong H, et al
    The Tryptophan-Rich Motif of HIV-1 Gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of Gp41 and Its Inhibitors.
    J Virol. 2019 Oct 16. pii: JVI.01358-19. doi: 10.1128/JVI.01358.
    >> Share

  26. MAVIGNER M, Zanoni M, Tharp GK, Habib J, et al
    Pharmacological modulation of the Wnt/beta-catenin pathway inhibits proliferation and promotes differentiation of long-lived memory CD4(+) T-cells in ART-suppressed SIV-infected macaques.
    J Virol. 2019 Oct 16. pii: JVI.01094-19. doi: 10.1128/JVI.01094.
    >> Share

  27. LONG S, Fennessey CM, Newman L, Reid C, et al
    Evaluating the intactness of persistent viral genomes in SIV-infected rhesus macaques initiating antiretroviral therapy within one year of infection.
    J Virol. 2019 Oct 9. pii: JVI.01308-19. doi: 10.1128/JVI.01308.
    >> Share

  28. MASSANELLA M, Bakeman W, Sithinamsuwan P, Fletcher JLK, et al
    Infrequent HIV infection of circulating monocytes during antiretroviral therapy.
    J Virol. 2019 Oct 9. pii: JVI.01174-19. doi: 10.1128/JVI.01174.
    >> Share

  29. LUO X, Herzig E, Doitsh G, Grimmett ZW, et al
    HIV-2 depletes CD4 T cells through pyroptosis despite Vpx-dependent degradation of SAMHD1.
    J Virol. 2019 Oct 2. pii: JVI.00666-19. doi: 10.1128/JVI.00666.
    >> Share

    October 2018
  30. SOARE AY, Durham ND, Gopal R, Tweel B, et al
    P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1beta in a human tonsil explant model.
    J Virol. 2018 Oct 10. pii: JVI.01186-18. doi: 10.1128/JVI.01186.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016